| 1 | 5 ASA, enemas, suppositories, corticosteroids | - | - | - | - | 1件: 97 97 💬
|
| 2 | Acei/ARB and corticosteroids | - | - | - | - | 1件: 66 66 💬
|
| 3 | Azithromycin + N-acetylcystein + inhaled corticosteroid | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 228 228 💬
|
| 4 | Chronic corticosteroid therapy | - | - | - | - | 1件: 113 113 💬
|
| 5 | Combined plasma exchange (PEX), rituximab, and corticosteroids | - | - | - | - | 1件: 85 85 💬
|
| 6 | Corticosteroid | - | - | - | - | 7件: 13 13, 66, 84, 96, 97, 113, 222 💬
|
| 7 | Corticosteroid and azathioprine | - | - | - | - | 4件: 42 42, 43, 44, 45 💬
|
| 8 | Corticosteroid injection | - | - | - | - | 1件: 46 46 💬
|
| 9 | Corticosteroid or nsaid | - | - | - | - | 1件: 46 46 💬
|
| 10 | Corticosteroide | - | - | - | - | 1件: 113 113 💬
|
| 11 | Corticosteroids | - | - | - | - | 12件: 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
|
| 12 | Corticosteroids & tancart19/20 | - | - | - | - | 1件: 13 13 💬
|
| 13 | Corticosteroids and immunosuppressants | - | - | - | - | 1件: 55 55 💬
|
| 14 | Corticosteroids combined with immunoglobulin and romiplostim | - | - | - | - | 1件: 63 63 💬
|
| 15 | Corticosteroids FOR systemic USE | - | - | - | - | 1件: 41 41 💬
|
| 16 | Corticosteroids only | - | - | - | - | 1件: 97 97 💬
|
| 17 | Corticosteroids'therapy | - | - | - | - | 1件: 35 35 💬
|
| 18 | CS (corticosteroids) only | - | - | - | - | 1件: 97 97 💬
|
| 19 | Cumulative corticosteroid exposure | - | - | - | - | 1件: 49 49 💬
|
| 20 | Daratumumab and corticosteroid treatment | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 288 288 💬
|
| 21 | Duchenne muscular dystrophy group without corticosteroids therapy | - | - | - | - | 1件: 113 113 💬
|
| 22 | H02 - corticosteroidi sistemici | - | - | - | - | 1件: 299 299 💬
|
| 23 | Immediate treatment with corticosteroids | - | - | - | - | 1件: 11 11 💬
|
| 24 | Intra-articular corticosteroid injection | - | - | - | - | 1件: 46 46 💬
|
| 25 | IV corticosteroid | - | - | - | - | 1件: 97 97 💬
|
| 26 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO methylprednisolone | - | - | - | - | 1件: 97 97 💬
|
| 27 | Oral corticosteroids | - | - | - | - | 4件: 13 13, 46, 97, 251 💬
|
| 28 | Prophylactic corticosteroid taper regimen | - | - | - | - | 1件: 251 251 💬
|
| 29 | Reactive corticosteroid taper regimen | - | - | - | - | 1件: 251 251 💬
|
| 30 | Rituximab combined with corticosteroids | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬
|
| 31 | Rituximab, cyclophosphamide, and corticosteroids | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬
|
| 32 | SOC corticosteroid - induction period | - | - | - | - | 1件: 96 96 💬
|
| 33 | SOC corticosteroid - tapering | - | - | - | - | 1件: 96 96 💬
|
| 34 | Treatment with topical superpotent corticosteroid therapy | - | - | - | - | 1件: 162 162 💬
|
| 35 | Valproid acid plus corticosteroids | - | - | - | - | 1件: 26 26 💬
|
